Skip to content
Open menu

Assessing the risk of hereditary breast cancer

Breast cancer is the most common cancer among women. In nearly 30 % of all cases, a member of the breast cancer patient’s extended family also has breast cancer. This may be coincidental or due to hereditary susceptibility.

According to estimates, a single gene mutation that runs in the family underlies approximately 5–10 % of all breast cancer cases. The most common form of such mutations are BRCA gene defects.

Indications of hereditary breast cancer include:

  • Breast cancer in a very young person
  • Multiple cancers in one person
  • Breast cancer in both breasts
  • Incidences of breast cancer and/or ovarian cancer in close kin

How can breast cancer heredity be examined?

How can the heredity of cancer be examined if you have a nagging doubt and have observed some of the indications mentioned above? At Docrates Cancer Center, we provide two alternative paths. A sensible approach is to discuss the cancer cases in your family with a specialist in medical genetics. If the situation seems to indicate the chance of hereditary breast cancer, a genetic test to investigate heredity will be recommended. The test is best suited for people who have actually already suffered from cancer. If a genetic defect is discovered, efforts will be made to identify all the carriers of the defective gene in the family. Even if a family shows hereditary susceptibility to cancer, it does not mean that all family members have inherited it.

However, if a customer wishes, another approach can also be adopted. A genetic risk test can be performed immediately on the basis of the customer’s concern or his or her own assessment, whereafter the situation and the significance of the test can be discussed with a geneticist when the results of the gene test are known. The interpretation of the results always depends on the patient’s and his or her family’s situation. In other words, if the genetic risk test does not reveal any harmful variant associated with an increased risk of developing cancer, it does not necessarily mean that the person in question could not have inherited cancer susceptibility, which is why he or she would require more accurate monitoring than usual.

Read more

Breast reconstruction surgery means meticulous craftsmanship by experienced surgeons

Reconstructing a removed breast is part of the treatment path of many breast cancer patients. The goal of the surgery...

Read more

Chief Clinical Director of Docrates Cancer Center: “Genetic information is an essential part of modern cancer care”

New forms of treatment based on molecular diagnostics enable more and more patients to completely recover from cancer, and make...

Customer message 3. September, 2024

With a transaction signed on 2 September 2024, Mehiläinen has acquired Docrates Ltd, as a result of which Docrates Cancer...

The competition authority issues its decision on the merger of Mehiläinen and Docrates Cancer Center

On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010

Contact us!

Mon-Thu 8:00-18:00, Fri 8:00-16:00